Showing results (1-10 of 921) with videos related to
Sort By:
Pageof 93
Zeitschrift Fur Rheumatologie|May 23, 2024
[CAR T-cell therapy in rheumatology-What we know so far?]Melanie Hagen, Andreas Wirsching, Daniela Bohr, et al.Plos Medicine|July 20, 2026
Progress and promise of CAR-T cell treatment in autoimmune diseasesJule Bachl, Melanie Hagen, Georg SchettThe Journal of Rheumatology|September 15, 2025
Effects of CD19 CAR T Cell Therapy on Quality of Life and Direct Healthcare Costs in Systemic Lupus Erythematosus: A Preliminary AnalysisJule Taubmann, Melanie Hagen, Fabian Müller, et al.Innere Medizin (Heidelberg, Germany)|June 30, 2025
[CAR T cells in non-malignant diseases]Fabian Müller, Melanie Hagen, Georg Schett, et al.Zeitschrift Fur Rheumatologie|September 4, 2025
[Long-term follow up of efficiency and safety of CD19-CAR T-cell treatment of systemic lupus erythematosus]Jule Taubmann, Sebastian Böltz, Melanie Hagen, et al.Rheumatology (Oxford, England)|September 11, 2021
IgA anti-citrullinated protein antibodies are associated with flares during DMARD tapering in rheumatoid arthritisMaria V Sokolova, Melanie Hagen, Holger Bang, et al.RMD Open|June 29, 2026
Real-world longitudinal assessment of anifrolumab in patients with systemic lupus erythematosus: clinical outcomes, safety and modulation of cytokines and neutrophil activityAlp Temiz, Rita Noversa de Sousa, Janina Schoen, et al.Autoimmunity Reviews|November 12, 2024
Harnessing the potential of CAR-T cell in lupus treatment: From theory to practiceTamim Alsuliman, Zora Marjanovic, Doron Rimar, et al.Cell Adhesion & Migration|March 6, 2009
How does joint remodeling work?: new insights in the molecular regulation of the architecture of jointsGeorg SchettBest Practice & Research. Clinical Rheumatology|December 10, 2017
The role of ACPAs in at-risk individuals: Early targeting of the bone and jointsGeorg SchettPageof 93